Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes.
Mitsuyoshi TakaharaToshihiko ShiraiwaTaka-Aki MatsuokaKaoru YamamotoYoshifumi MaenoYuka ShiraiwaYoko YoshidaNaoto KatakamiHiroaki IijimaHideyuki KatsumataKenji ArakawaToshio HashimotoIichiro ShimomuraPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
UMIN000030208/jRCTs051180036.
Keyphrases